We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Wednesday broker round-up

Wed, 03rd Mar 2021 13:05

(Sharecast News) - Croda International: Berenberg reiterates buy with a target price of 7,400p.



Biffa: Berenberg reiterates buy with a target price of 300p.

Travis Perkins: Canaccord reiterates hold with a target price of 1,525p.

Taylor Wimpey: Canaccord reiterates buy with a target price of 193p.

Croda: Barclays reiterates underweight with a target price of 6,000p.

Metro Bank: Barclays reiterates underweight with a target price of 130p.

Ashtead Group: Barclays reiterates overweight with a target price of 4,340p.

Avast: Peel Hunt reiterates sell with a target price of 355p.

Beazley: Peel Hunt reiterates hold with a target price of 330p.

Serco Group: Liberum reiterates buy with a target price of 180p.

GetBusy: Liberum reiterates buy with a target price of 130p.

BP: JP Morgan reiterates overweight with a target price of 440p.

Man Group: JP Morgan reiterates overweight with a target price of 180p.

Anglo Pacific Group: RBC Capital Markets reiterates outperform with a target price of 240p.

Flutter Entertainment: RBC Capital Markets reiterates sector perform with a target price of 15,700p.

Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,000p.

Bunzl: Deutsche Bank reiterates buy with a target price of 2,850p.

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.